RESUMEN

The aim of this study was to evaluate in vitro the permeation of the antioxidant agent Idebenone (IDE) loaded into solid lipid nanoparticles (SLN) across MDCKII-MDR1 cell monolayer, selected as an in vitro model of the Blood Brain Barrier (BBB). SLN were prepared using cetyl palmitate as solid lipid and different non-ionic surfactants, oleth-20, ceteth-20 and isoceth-20, by the phase inversion temperature (PIT) technique. The resulting SLN showed physiological pH and osmolarity values, a mean particle diameter in the range of 33-63 nm, a single peak in size distribution, and a zeta potential ranging from +3.14 to -2.89 mV. When incubating these SLN in Simulated Body Fluid (SBF), the particle size was maintained for all samples throughout the study. IDE permeability across MDCKII-MDR1 cell monolayers from the SLN under investigation was 0.40-0.53 fold lower than free IDE and no significant difference was observed comparing IDE permeation from all the SLN tested. It is noteworthy that IDE loading into SLN avoided the use of an organic solvent to solubilize IDE, a poor water soluble compound, allowing the parenteral administration of this drug in aqueous vehicles. Furthermore, the results of in vitro transport studies, performed using fluorescein-dextran 4000 (FD4) and diazepam (DZ) as markers of the paracellular pathway and the transcellular pathway, respectively, pointed out that IDE could permeate via a transcellular pathway. Therefore, these novel nanocarriers could be regarded as a promising strategy to design delivery systems for IDE administration to the brain, deserving further investigations under in vivo conditions.

Asunto(s)

Barrera Hematoencefálica/química , Lípidos/química , Nanocápsulas/química , Ubiquinona/análogos & derivados , Animales , Antioxidantes/administración & dosificación , Antioxidantes/química , Difusión , Perros , Ensayo de Materiales , Ubiquinona/administración & dosificación , Ubiquinona/química

RESUMEN

The purpose of this study was to evaluate the potential use of two novel solid formulations of valproic acid (VPA) prepared by complexation with hydrophilic cyclodextrins (CDs) as hydroxypropyl-beta- and sulfobutylether-beta-cyclodextrin and by solid dispersion (SD) in hydrophilic carriers as polyethylene glycol 6000 (PEG 6000) and polyvinylpyrrolidone K-30 (PVP K-30). The corresponding cyclodextrin-based complexes were prepared by the freeze-drying method while the solid dispersions were obtained by the solvent method. Valproic acid solubility improved by CDs complexation and solid dispersion techniques. Comparison of dissolution profiles with that of VPA sodium salt (NaVP) was made by using release parameters such as dissolution efficiency, percent of drug dissolved after 60 min, and difference and similarity factors. Based on difference and similarity factors, it can be concluded that all the VPA formulations possess dissolution profiles essentially equivalent to those of NaVP at pH 6. However, this conclusion is not confirmed by using the analysis of variance (ANOVA) approach, indicating some significant differences between some SD-based formulations and NaVP at that pH value. Preliminary pharmacological studies in the pentylenetetrazole test in rats showed some important differences among the SD-based formulations, NaVP, and VPA as oil/water emulsion. Some implications and limitations of the investigated formulations are discussed.

Asunto(s)

Anticonvulsivantes/química , Ciclodextrinas/química , Ácido Valproico/química , Algoritmos , Animales , Anticonvulsivantes/administración & dosificación , Anticonvulsivantes/farmacología , Rastreo Diferencial de Calorimetría , Cromatografía Líquida de Alta Presión , Convulsivantes , Portadores de Fármacos , Excipientes , Femenino , Espectroscopía de Resonancia Magnética , Masculino , Pentilenotetrazol , Polietilenglicoles , Povidona , Ratas , Ratas Sprague-Dawley , Convulsiones/inducido químicamente , Convulsiones/prevención & control , Solubilidad , Espectrofotometría Ultravioleta , Ácido Valproico/administración & dosificación , Ácido Valproico/farmacología

RESUMEN

The 2-phenyl-imidazo[1,2-a]pyridine derivative CB 34 is a ligand for peripheral benzodiazepine receptors. The binding of [3H]CB 34 to rat cerebrocortical membranes was characterized. Specific binding was rapid, reversible, saturable and of high affinity. Kinetic analysis yielded association and dissociation rate constants of 0.2x10(8) M(-1) min(-1) and 0.29 min(-1), respectively. Saturation binding experiments revealed a single class of binding sites with a total binding capacity of 188+/-8 fmol/mg protein and an apparent dissociation constant of 0.19+/-0.02 nM. Specific [3H]CB 34 binding was inhibited by ligands selective for peripheral benzodiazepine receptors, whereas, with the exception of flunitrazepam and diazepam, ligands for central benzodiazepine receptors were inactive. Of the brain regions examined, the density of the [3H]CB 34-binding sites was greatest in the hypothalamus and lowest in the cerebral cortex. [3H]CB 34 is thus a potent and selective ligand for peripheral benzodiazepine receptors and should be proven useful for studies of the roles of these receptors.

Asunto(s)

Benzodiazepinas , Encéfalo/metabolismo , Imidazoles/metabolismo , Membranas/metabolismo , Nordazepam/análogos & derivados , Piridinas/metabolismo , Receptores de GABA-A/metabolismo , Animales , Ansiolíticos/farmacología , Benzodiazepinonas/farmacología , Unión Competitiva/efectos de los fármacos , Encéfalo/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Flumazenil/farmacología , Imidazoles/farmacología , Ácidos Indolacéticos/farmacología , Isoquinolinas/farmacología , Ligandos , Proteínas de la Membrana/efectos de los fármacos , Proteínas de la Membrana/metabolismo , Membranas/efectos de los fármacos , Nordazepam/farmacología , Piridinas/farmacología , Ratas , Ratas Sprague-Dawley , Tritio

RESUMEN

The imidazobenzothiazole compounds 3-17 together with the imidazobenzoxazole 18, and the imidazobenzoimidazole 19 were prepared and their cytotoxic activity evaluated at the National Cancer Institute (NCI) for testing against a panel of approximately 60 tumor cell lines. Compounds 5, 7, 8, and 16 exhibited interesting in vitro cytotoxic activity. The most active imidazobenzothiazole derivative 8 was further evaluated as a cytotoxic agent in the hollow fiber assay and showed a score greater than the minimum values for xenograft testing together with a net cell kill. Comparison with the results displayed in the in vivo assay by standard antitumor drugs in clinical use revealed a significant in vivo activity of the benzothiazole compound. COMPARE analyses for compounds 4-19 against the NCI's standard agent database show poor or no correlation, and it might suggest for these compounds a mechanism of action unrelated to that of any known drug. Furthermore, the benzothiazole 8 did not show significant antitumor activity in a panel of two xenotransplanted tumors (i.e. colon and non-small cell lung tumors). By computing the polar surface area of compounds 3-19 with the MAREA computer program it was established that the most active compounds 5, 7, 8, and 16 should experience good intestinal permeability.

Asunto(s)

Antineoplásicos/síntesis química , Tiazoles/síntesis química , Animales , Antineoplásicos/farmacología , Benzotiazoles , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Neoplasias del Colon/tratamiento farmacológico , Evaluación Preclínica de Medicamentos , Humanos , Absorción Intestinal , Neoplasias Pulmonares/tratamiento farmacológico , Ratones , Estructura Molecular , Trasplante de Neoplasias , Programas Informáticos , Relación Estructura-Actividad , Tiazoles/metabolismo , Tiazoles/farmacología , Células Tumorales Cultivadas/efectos de los fármacos

RESUMEN

Solid dispersions of phenytoin in polyethylene glycol 6000 and polyvinylpyrrolidone K-30 with different drug-to-carrier ratios were prepared by the solvent method with the aim of increasing dissolution rate and bioavailability of the drug. These new formulations were characterized in the solid state by FT-IR spectroscopy, X-ray powder diffraction, and differential scanning calorimetry. Drug solubility and dissolution rate are improved by these formulations, particularly with SDPEG 1/20 and SDPVP 1/20 systems. Storage was found to influence the stability of the solid dispersions. By maximal electroshock test, it was found that the intraperitoneal administration in mice of the SDPEG 1/20 and SDPVP 1/20 systems exhibited anticonvulsant activity similar to diphenylhydantoin sodium salt.

Asunto(s)

Anticonvulsivantes/química , Fenitoína/química , Povidona/química , Animales , Anticonvulsivantes/uso terapéutico , Química Farmacéutica , Combinación de Medicamentos , Masculino , Ratones , Excipientes Farmacéuticos/química , Fenitoína/uso terapéutico , Povidona/uso terapéutico , Convulsiones/prevención & control , Solubilidad , Espectroscopía Infrarroja por Transformada de Fourier

RESUMEN

The main objective of this study was to evaluate the influence of hydroxypropylated beta- and gamma-cyclodextrins and Me-beta-cyclodextrin (HP-beta-CD, HP-gamma-CD, and Me-beta-CD, respectively) on the dissolution rate and bioavailability of the antiepileptic agent, phenytoin (DPH). The corresponding solid complexes were prepared by a freeze-drying method and characterized by infrared spectroscopy, X-ray powder diffraction, and differential scanning calorimetry studies. Evidence of inclusion complex formation in the case of HP-beta-CD was obtained by (1)H- and (13)C-nuclear magnetic resonance spectroscopy. Drug solubility and dissolution rate in 0.05 M potassium phosphate buffer (pH 6) were notably improved by employing the beta-CDs. Thus a 45% w/v HP-beta-CD or Me-beta-CD solution gave rise to an increase of dissolved drug of 420- and 578-fold, respectively. The Q(10) (i.e. percentage of dissolved DPH at 10 min) was 5.2% for the pure drug and 93, 98, and 96% for DPH/HP-beta-CD, DPH/HP-gamma-CD, and DPH/Me-beta-CD complexes, respectively. Moreover, it was found that in the maximal electroshock seizure test in mice the DPH/Me-beta-CD complex exhibited anticonvulsant activity similar to DPH sodium salt (NaDPH).

Asunto(s)

Anticonvulsivantes/administración & dosificación , Ciclodextrinas/administración & dosificación , Fenitoína/administración & dosificación , Animales , Estabilidad de Medicamentos , Espectroscopía de Resonancia Magnética , Masculino , Ratones , Fenitoína/química , Fenitoína/uso terapéutico , Solubilidad , Espectroscopía Infrarroja por Transformada de Fourier , Difracción de Rayos X

RESUMEN

The effect of some chemically modified cyclodextrins [namely, 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin (HP-beta-CD, Me-beta-CD, and HP-gamma-CD, respectively)] on the aqueous solubility and dissolution rate of the hypnotic agent Zolpidem (ZP) was investigated. Solid complexes were prepared by freeze drying and characterized by infrared spectroscopy, X-ray powder diffraction, and differential scanning calorimetry. The solubility and dissolution rate of the drug were significantly improved by complexation with HP-beta-CD or Me-beta-CD. The structure of the inclusion complex ZP-HP-beta-CD in CH(3)COOD/D(2)O was investigated by (1)H and (13)C NMR spectroscopy, including NOE measurements. These measurements revealing a weak interaction between the tolyl moiety of the guest molecule and the HP-beta-CD cavity. The ataxic activity in rat was also investigated and it was found that ZP-HP-beta-CD and ZP-Me-beta-CD complexes showed almost 2-fold longer ataxic induction times than controls.

Asunto(s)

Ciclodextrinas/química , Hipnóticos y Sedantes/química , Piridinas/química , beta-Ciclodextrinas , gamma-Ciclodextrinas , 2-Hidroxipropil-beta-Ciclodextrina , Animales , Ataxia/inducido químicamente , Ciclodextrinas/efectos adversos , Hipnóticos y Sedantes/efectos adversos , Masculino , Piridinas/efectos adversos , Ratas , Ratas Sprague-Dawley , Solubilidad , Zolpidem

RESUMEN

The substituent effects at positions 6 and 8 (compounds 17-31) as well as at the amide nitrogen (compounds 32-40) of a series of 2-phenylimidazo[1,2-a]pyridineacetamides were evaluated at both central (CBR) and peripheral (PBR) benzodiazepine receptors. The structure-activity relationship studies detailed herein indicate the key structural features required for high affinity and selectivity for PBR. Substitution on the imidazopyridine nucleus at position 8 with lipophilic substituents and the presence of one chlorine atom at the para position of the phenyl ring at C(2) are crucial features for high binding affinity and selectivity toward PBR. A small subset of active ligands (i.e., 17, 20, 26, 34, and 35) were evaluated in vitro in Xenopus oocytes expressing cloned human GABA(A) receptors for their effects at CBR and in vivo for their ability to stimulate the synthesis of neurosteroids such as pregnenolone, progesterone, allopregnanolone, and allotetrahydrodeoxycorticosterone (THDOC). Compounds 17, 20, 26, and 34 markedly increased the levels of neuroactive steroids in plasma and cerebral cortex, unlike compound 35.

Asunto(s)

Imidazoles/química , Piridinas/química , Receptores de GABA-A/metabolismo , Animales , Clonación Molecular , Desoxicorticosterona/análogos & derivados , Desoxicorticosterona/biosíntesis , Femenino , Humanos , Isoquinolinas/química , Isoquinolinas/farmacología , Ligandos , Masculino , Oocitos/efectos de los fármacos , Oocitos/metabolismo , Pregnenolona/biosíntesis , Progesterona/biosíntesis , Ratas , Ratas Sprague-Dawley , Relación Estructura-Actividad , Xenopus

RESUMEN

Solid dispersions and physical mixtures of Zolpidem in polyethylene glycol 4000 (PEG 4000) and 6000 (PEG 6000) were prepared with the aim to increase its aqueous solubility. These PEG based formulations of the drug were characterized in solid state by FT-IR spectroscopy, X-ray powder diffraction, and differential scanning calorimetry. By these physical determinations no drug-polymer interactions were evidenced. Both solubility and dissolution rate of the drug in these formulations were increased. Each individual dissolution profile of PEG based formulation fitted Baker-Lonsdale and first order kinetic models. Finally, significant differences in ataxic induction time were observed between Zolpidem orally administered as suspension of drug alone and as solid dispersion or physical mixture. These formulations, indeed, showed almost two- to three-fold longer ataxic induction times suggesting that, in the presence of PEG, the intestinal membrane permeability is probably the rate-limiting factor of the absorption process.

Asunto(s)

Hipnóticos y Sedantes/química , Polietilenglicoles/química , Piridinas/química , Animales , Ataxia/inducido químicamente , Rastreo Diferencial de Calorimetría , Fenómenos Químicos , Química Física , Hipnóticos y Sedantes/farmacocinética , Hipnóticos y Sedantes/farmacología , Absorción Intestinal/efectos de los fármacos , Cinética , Masculino , Polietilenglicoles/farmacocinética , Polietilenglicoles/farmacología , Piridinas/farmacocinética , Piridinas/farmacología , Ratas , Ratas Sprague-Dawley , Solubilidad , Espectroscopía Infrarroja por Transformada de Fourier , Difracción de Rayos X , Zolpidem

RESUMEN

1. Several derivatives and analogues of the general anaesthetic 2,6-diisopropylphenol (propofol) have been recently synthesised with the aim of exploring the structure-activity relationships. 2. In the present study, the effects of one such compound, 4-iodo-2,6-diisopropylphenol (4-I-Pro), on gamma-aminobutyric acid type A (GABA(A)) receptors in vitro were compared with its in vivo effects in rodents. Human GABA(A) receptors were expressed in Xenopus oocytes, and the actions of 4-I-Pro on receptor function were compared with those of propofol by two-electrode voltage-clamp recording. 3. Similar to propofol, 4-I-Pro directly activated Cl- currents in the absence of GABA at all combinations of receptor subunits tested. However, the efficacy of 4-I-Pro in inducing direct activation of alpha1beta2gamma2S receptors was markedly less than that of propofol. 4. Similarly to propofol, 4-I-Pro potentiated in a concentration-dependent manner GABA-evoked Cl- currents measured at different GABA(A) receptor constructs. 5. As expected, intraperitoneal injection of propofol induced sedation, ataxia, and loss of the righting reflex in rats. In contrast, administration of 4-I-Pro failed to produce any of these behavioural effects. 6. Administration of 4-I-Pro to rats reduced in a dose-dependent manner the incidence of tonic-clonic seizures induced by pentylenetetrazol and induced an anticonflict effect as measured in the Vogel test. 7. Microdialysis revealed that, like propofol, administration of 4-I-Pro reduced acetylcholine release in the hippocampus of freely moving rats. 8. These results demonstrate that para-substitution of the phenol ring of propofol with iodine yields a compound that exhibits anticonvulsant and anticonflict effects, but is devoid of sedative-hypnotic and anaesthetic properties. Thus, 4-I-Pro possesses pharmacological characteristics more similar to anxiolytic and anticonvulsant drugs than to general anaesthetics.

Asunto(s)

Anestésicos/farmacología , Hipnóticos y Sedantes/farmacología , Propofol/análogos & derivados , Propofol/farmacología , Acetilcolina/metabolismo , Animales , Ansiolíticos/farmacología , Anticonvulsivantes/farmacología , Canales de Cloruro/efectos de los fármacos , Conflicto Psicológico , Relación Dosis-Respuesta a Droga , Electrofisiología , Conducta Exploratoria/efectos de los fármacos , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Masculino , Potenciales de la Membrana/efectos de los fármacos , Ratones , Oocitos , Ratas , Ratas Sprague-Dawley , Receptores de GABA-A/efectos de los fármacos , Receptores de GABA-A/metabolismo , Convulsiones/tratamiento farmacológico , Xenopus , Ácido gamma-Aminobutírico/farmacología

RESUMEN

A number of propofol (2,6-diisopropylphenol) congeners and derivatives were synthesized and their in vitro capability to affect GABAA receptors determined by the inhibition of the specific [35S]-tert-butylbicyclophosphorothionate ([35S]TBPS) binding to rat whole brain membranes. Introduction of halogen (Cl, Br, and I) and benzoyl substituents in the para position of the phenyl group resulted in ligands with higher potency at inhibiting [35S]TBPS binding. A quantitative structure-affinity relationship (QSAR) study demonstrated that affinity is enhanced by increases in lipophilicity of the ligand whereas affinity is adversely affected by increases in size of the substituent para to the phenolic hydroxyl group. Consistent with the displacement of [35S]TBPS and with the activation of GABAA receptors, we demonstrate that ligands displaying high affinity (i.e., 2-4, and 8) are able to increase GABA-stimulated chloride currents in oocytes expressing human GABAA receptors and to directly activate chloride currents in an electrophysiological assay. Among them, compound 4 showed a rather peculiar profile in the electrophysiological examination with cloned alpha1beta2gamma2 GABAA receptors. Indeed, compared to propofol, it displayed a much greater efficacy at potentiating GABA-elicited chloride currents, but a much lower efficacy at producing a direct activation of the chloride channel in the absence of GABA. This behavior may give to compound 4 pharmacological properties that are more similar to anxiolytic and anticonvulsant drugs than to those of general anesthetics.

Asunto(s)

Anestésicos Intravenosos , Corteza Cerebral/efectos de los fármacos , Propofol , Propofol/análogos & derivados , Receptores de GABA-A/metabolismo , Anestésicos Intravenosos/metabolismo , Anestésicos Intravenosos/farmacología , Animales , Compuestos Bicíclicos Heterocíclicos con Puentes/metabolismo , Corteza Cerebral/metabolismo , Agonistas de los Canales de Cloruro , Femenino , Humanos , Técnicas In Vitro , Oocitos/metabolismo , Oocitos/fisiología , Técnicas de Placa-Clamp , Propofol/síntesis química , Propofol/química , Propofol/metabolismo , Propofol/farmacología , Ratas , Receptores de GABA-A/biosíntesis , Receptores de GABA-A/efectos de los fármacos , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/metabolismo , Relación Estructura-Actividad , Xenopus laevis

RESUMEN

An aqueous formulations of propofol 1 can be prepared by solubilizing it in the presence of 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CD). This is potentially useful for parenteral administration of the drug. The aqueous solubility of 1 linearly increased as a function of HP-beta-CD concentration and showed features of an AL type diagram. Thermodynamic parameters were obtained by using the temperature dependence of the stability constant at temperatures of between 25 and 37 degrees C. The results indicate that complex formation is enthalpically, rather than entropically, driven and that it may involve van der Waals (dispersive) forces, rather than hydrophobic interactions. The structure of the inclusion complex propofol/HP-beta-CD was investigated in D2O, using 1H and 13C NMR spectroscopy. These studies revealed that the whole aromatic ring, as well as part of the isopropyl groups of the guest molecule, is located inside the HP-beta-CD cavity, while the hydroxy group is located at the rim of the wider cavity end. The geometrical features of the inclusion complex 1-HP-beta-CD are confirmed by 1D NOE difference spectra and molecular modeling experiments. The anesthetic activity in rat was investigated, and it was found that there are significant differences in induction time and sleeping time between 1 solubilized in the presence of HP-beta-CD and the formulation currently used (Diprivan), which is a 1% w/v oil/water emulsion.

Asunto(s)

Anestésicos Intravenosos/farmacología , Ciclodextrinas/química , Propofol/química , beta-Ciclodextrinas , 2-Hidroxipropil-beta-Ciclodextrina , Animales , Ciclodextrinas/farmacología , Espectroscopía de Resonancia Magnética , Masculino , Modelos Moleculares , Propofol/farmacología , Ratas , Ratas Sprague-Dawley , Solubilidad

RESUMEN

A number of 6-substituted or 6,8-disubstituted alkyl 2-phenylimidazo[1,2-alpha]pyridine-3-carboxylates 5a-h, -acetates 5i-s, 6a-g, and -propionates 5t, 6h and of N,N-dialkyl-2-phenylimidazo[1,2-alpha]pyridine-3-carboxamides 7a-d,-acetamides 7e-t or -propionamide 7u were prepared following new synthetic methods, and their affinities for both the central (CBR) and the peripheral (PBR) benzodiazepine receptors evaluated. The compounds of the ester series displayed low affinity for both receptor types. Conversely, most of N,N-dialkyl(2-phenylimidazo[1,2-alpha]pyridin-3-yl)acetamides 7e-t proved to possess high affinity and selectivity for CBR or PBR depending on the nature of substituents at C(6)- and/or C(8) on the heterocyclic ring system. In particular, the 6-substituted compounds 7f-n displayed ratios of IC50 values (IC50(CBR)/IC50(PBR)) ranging from 0.32 (7m) to 232 (7k), while the 6,8-disubstituted compounds 7o-t were more than 1000-fold more selective for PBR versus CBR. Compounds 7f,m were examined in several different benzodiazepine receptor subtypes. Expression of specific GABAA, receptor subunit assemblies in Xenopus oocytes was utilized to evaluate functionally both the efficacy and potency of the positive modulation of GABA-evoked Cl- currents by 7f and 7m in comparison with Zolpidem. The rank order of potencies of these drugs was 7f (EC50 = 3.2 x 10(-8) M) > Zolpidem (EC50 = 3.6 x 10(-8) M) > 7m (EC50 = 2.2 x 10(-7) M). The actions of these compounds were also tested on alpha 2 beta 2 gamma 2s, receptors. However, the EC50 of these compounds was increased, compared to alpha 1 beta 2 gamma 2s receptors, by 30-, 4-, and 5-fold for 7m, 7f, and Zolpidem, respectively. Finally, these compounds were almost completely devoid of activity at receptors containing the alpha 5 subunit.

Asunto(s)

Encéfalo/metabolismo , Hipnóticos y Sedantes/síntesis química , Imidazoles/síntesis química , Riñón/metabolismo , Piridinas/síntesis química , Receptores de GABA-A/fisiología , Animales , Benzodiazepinonas/metabolismo , Unión Competitiva , Femenino , Flunitrazepam/metabolismo , Humanos , Hipnóticos y Sedantes/química , Hipnóticos y Sedantes/farmacología , Imidazoles/química , Imidazoles/farmacología , Cinética , Masculino , Mitocondrias/metabolismo , Estructura Molecular , Oocitos/efectos de los fármacos , Oocitos/fisiología , Piridinas/química , Piridinas/farmacología , Ensayo de Unión Radioligante , Ratas , Ratas Wistar , Receptores de GABA-A/biosíntesis , Receptores de GABA-A/efectos de los fármacos , Proteínas Recombinantes/efectos de los fármacos , Proteínas Recombinantes/metabolismo , Relación Estructura-Actividad , Xenopus laevis , Zolpidem

RESUMEN

To identify more potent anticonvulsant agents and to gain insights into the structural properties determining the potency of a new class of anticonvulsants, some 3a-substituted tetrahydropyrrolo[2,1-b]benzothiazol-1-ones (1a-d) and the thiazole and oxazole analogues (2a-c and 3a-c, respectively) have been synthesized and tested for anticonvulsant activity against isoniazid-induced seizures in rodents. The most active compound, 2a, with a median effective dose (ED50, i.p.) of 24.3 mg kg-1 and 15.9 mg kg-1 in mice and in rats, respectively, was more extensively investigated and found to strengthen the effects of diazepam. No clear correlation was observed between the anticonvulsant activity and molecular lipophilicity descriptors of compounds 1-3. Structural similarity between the antiepileptic drug phenobarbital and compounds 1-3 was evidenced by molecular modelling studies and used to derive preliminary structure-activity relationships. The results demonstrate that 2a is an attractive candidate as an anticonvulsant agent worthy of further study and may help the design of other anticonvulsant drugs.

Asunto(s)

Anticonvulsivantes/síntesis química , Anticonvulsivantes/farmacología , Pirrolidinas/síntesis química , Pirrolidinas/farmacología , Convulsiones/prevención & control , Tiazoles/síntesis química , Tiazoles/farmacología , Animales , Evaluación Preclínica de Medicamentos , Isoniazida , Masculino , Ratones , Ratas , Ratas Sprague-Dawley , Convulsiones/inducido químicamente

RESUMEN

The title compounds 7a-d and 8a-e were synthesized and their in vitro inhibitory activity of angiotensin-converting enzyme (ACE) was examined. In general, these compounds possess poor ACE inhibitory activity. Among the benzothiazinone compounds, which are generally more active than the cyclohomologous compounds 7, 8b is the most effective (IC50 of 170 microM).

Asunto(s)

Inhibidores de la Enzima Convertidora de Angiotensina/síntesis química , Tiazepinas/síntesis química , Inhibidores de la Enzima Convertidora de Angiotensina/química , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Captopril/farmacología , Evaluación de Medicamentos , Espectrofotometría , Relación Estructura-Actividad , Tiazepinas/química , Tiazepinas/farmacología

RESUMEN

Several N-alkenyl-2-acylalkylidene-2,3-dihydro-1,3-benzothiazoles (4) were synthesized and tested for in vitro antibacterial activity against different Gram-positive and Gram-negative bacteria. Compounds 4 were also tested for antifungal activity against Saccharomyces cerevisiae. The findings clearly showed that all the compounds 4 were devoid of antifungal activity, whereas the compounds 4i-m,o-r were effective against the bacterial strains used. Compounds 4k,m,p,q proved to be the most active antibacterial agents showing in some cases minimum inhibitory concentrations (MIC) lower than chloramphenicol and gentamicin, used as reference compounds. In the case of two representative bacterial strains (Gram-positive and Gram-negative, respectively), a parabolic relationship was found between the antibacterial activity of compounds 4i-m,o-r expressed as log1/MIC and the molecular lipophilicity measured as RM values.

Asunto(s)

Antiinfecciosos/síntesis química , Tiazoles/síntesis química , Antibacterianos , Antiinfecciosos/farmacología , Antifúngicos/síntesis química , Antifúngicos/farmacología , Fenómenos Químicos , Química Física , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Grampositivas/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Saccharomyces cerevisiae/efectos de los fármacos , Relación Estructura-Actividad , Tiazoles/farmacología

RESUMEN

The pyrrolo[2,1-c][1,4]benzothiazines 2a-n and the pyrrolo[2,1-c][1,4]thiazine 13 were prepared and tested for their ability to displace specific [3H]diazepam binding from rat brain membranes. Such compounds were found essentially devoid of binding affinity for the benzodiazepine receptor.

Asunto(s)

Encéfalo/metabolismo , Pirroles/síntesis química , Receptores de GABA-A/metabolismo , Tiazinas/síntesis química , Animales , Fenómenos Químicos , Química , Técnicas In Vitro , Pirroles/metabolismo , Ratas , Tiazinas/metabolismo

RESUMEN

The pyrido[2,1-c][1,4]benzothiazines 1a-t and the pyrido[2,1-c][1,4]thiazines 7a,b were prepared and tested for their ability to displace specific [3H]diazepam binding from rat brain membranes. Some of the examined compounds of type 1 and 7b showed moderate binding affinity for the benzodiazepine receptor.

Asunto(s)

Encéfalo/metabolismo , Piridinas/síntesis química , Receptores de GABA-A/metabolismo , Tiazinas/síntesis química , Animales , Fenómenos Químicos , Química , Técnicas In Vitro , Piridinas/metabolismo , Ratas , Tiazinas/metabolismo

RESUMEN

A new series of dihydro-4H-1,4-benzothiazine derivatives was prepared. These compounds were obtained by reductive N-alkylation reaction with sodium borohydride in acetic acid of the corresponding 4H-1,4-benzothiazine. Some of the latter compounds were synthesized by a new synthetic method employing 2-aminobenzenethiol and alkynes as starting material. Preliminary pharmacological data on the antiinflammatory activity of these compounds by using carrageenin paw edema assay are reported.

Asunto(s)

Antiinflamatorios/síntesis química , Tiazinas/síntesis química , Animales , Ratas , Ratas Endogámicas , Tiazinas/farmacología